申请人:Allergan, Inc.
公开号:US20150209351A1
公开(公告)日:2015-07-30
Compounds are described herein useful for treating diseases and conditions by modulation of one or more alpha adrenergic receptor. The compounds can include a naphthalene, a quinoline, a benzoimidazole or an isoquinoline as a core structure. Methods of making, using and formulating these compounds are described.
本文描述了一些化合物,通过调节一个或多个α肾上腺素受体,可用于治疗疾病和病况。这些化合物可以包括萘、喹啉、苯并咪唑或异喹啉作为核心结构。描述了制备、使用和配制这些化合物的方法。